Actively Recruiting
Efficacy of Percutaneous Electrolysis Treatment for Hip Pain in Male Ice Hockey Players: a Pilot Study
Led by Veronique Vidal · Updated on 2026-06-02
6
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Groin pain is a common and limiting issue for male ice hockey players, often caused by the intense mechanical demands on the hip during skating. This research focuses on the relationship between the iliopsoas muscle and the anterior hip capsule, which may contribute to hip-related groin pain. The study aims to explore the effects of percutaneous needle electrolysis (PNE) on improving hip function by reducing pain and enhancing mobility and muscle strength in this group. Participants will undergo three sessions of ultrasound-guided musculoskeletal percutaneous electrolysis applied to the anterior hip capsule. This minimally invasive technique uses a fine needle and a controlled galvanic current to promote tissue remodeling and reduce inflammation. Treatment is performed under sterile conditions by a qualified clinician experienced in ultrasound-guided physiotherapy. During the study, assessments will be done before treatment, immediately after the three sessions, and at a 4-week follow-up. Researchers will measure hip flexor strength, hip flexion range of motion, results of the FADIR test, and patient-reported outcomes using the Hip and Groin Outcome Score (HAGOS). These evaluations will help understand the potential benefits of PNE for hip-related groin pain in male ice hockey players aged 18 to 21 years.
CONDITIONS
Brief Title
Efficacy of Ultrasound-Guided Percutaneous Electrolysis for Hip Pain in Male Ice Hockey Players
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male ice hockey players under 21 years old
- Age between 18 and 21 years
- Presence of groin pain or pain in the front of the hip
- Positive FADIR test result
- Ability to participate in regular training activities
- Willingness to participate and provide informed consent
You will not qualify if you...
- Having other orthopedic or systemic medical conditions
- Fear of needles (belonephobia)
- Contraindications to invasive physiotherapy such as infections, skin lesions at the treatment site, bleeding disorders, or allergies to metals
- Using other treatments targeting the hip during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of treatment sessions is not explicitly specified; treatment includes three sessions.
Participants receive three sessions of ultrasound-guided musculoskeletal percutaneous electrolysis applied to the anterior capsule of the hip to reduce pain and improve hip function.
3 visits (in-person) for treatment sessions
Duration - 4 weeks
Participants are assessed for hip and groin symptoms, hip flexor strength, hip flexion range of motion, and hip-related symptoms using clinical tests and questionnaires after the treatment period.
2 visits (in-person) at 2-3 days post-intervention and at 4-week follow-up
Trial Site Locations
Total: 1 location
1
Gottardo Arena
Ambrì, Canton Ticino, Switzerland, 6775
Actively Recruiting
Research Team
V
Veronique Vidal, Physiotherapist
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here